Afuco™ Anti-CD200 ADCC Recombinant Antibody (Samalizumab), ADCC Enhanced (CAT#: AFC-TAB-210)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD200. Samalizumab is a humanized monoclonal antibody designed for oncology indications.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized (from mouse)
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Clone
  • Samalizumab
  • Applications
  • IF, IP, Neut, FuncS, ELISA, FC
  • Conjugate
  • Unconjugated
  • Generic Name
  • Samalizumab
  • Related Disease
  • Blood cancers

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Samalizumab; 1073059-33-2; Anti-CD200; ALXN6000; CD200; CD200 molecule; antigen identified by monoclonal MRC OX 2, CD200 antigen, MOX1, MOX2; OX-2 membrane glycoprotein; MRC; OX 2; CD200 antigen; MRC OX-2 antigen; antigen identified by monoclonal MRC OX-2; MOX1;

Related Resources

  • Biosimilar Overview
Please refer to Samalizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Samalizumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Samalizumab"

Anti-Human CD200 Recombinant Antibody (Samalizumab)
Recombinant monoclonal antibody to CD200. Samalizumab is a humanized monoclonal antibody designed for oncology indications.

See other products for "CD200"

Recombinant Antibody

Humanized Antibody

CAT Product Name Application Type
TAB-210 Anti-Human CD200 Recombinant Antibody (Samalizumab) IF, IP, Neut, FuncS, ELISA, FC, WB IgG2 / G4 - kappa

Neutralizing Antibody

Blocking Antibody

CAT Product Name Application Type
NEUT-303CQ Mouse Anti-CD200 Recombinant Antibody (clone OX-104) FC, IHC, Block Mouse IgG1, κ
NEUT-305CQ Mouse Anti-CD200 Recombinant Antibody (clone CBL367) ELISA, Block Mouse IgG1

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-TAB-210. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare